1. Home
  2. NRXP vs ASYS Comparison

NRXP vs ASYS Comparison

Compare NRXP & ASYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NRXP
  • ASYS
  • Stock Information
  • Founded
  • NRXP 2015
  • ASYS 1981
  • Country
  • NRXP United States
  • ASYS United States
  • Employees
  • NRXP N/A
  • ASYS N/A
  • Industry
  • NRXP Biotechnology: Pharmaceutical Preparations
  • ASYS Industrial Machinery/Components
  • Sector
  • NRXP Health Care
  • ASYS Technology
  • Exchange
  • NRXP Nasdaq
  • ASYS Nasdaq
  • Market Cap
  • NRXP 73.7M
  • ASYS 83.0M
  • IPO Year
  • NRXP N/A
  • ASYS N/A
  • Fundamental
  • Price
  • NRXP $2.14
  • ASYS $7.23
  • Analyst Decision
  • NRXP Strong Buy
  • ASYS
  • Analyst Count
  • NRXP 5
  • ASYS 0
  • Target Price
  • NRXP $31.60
  • ASYS N/A
  • AVG Volume (30 Days)
  • NRXP 480.7K
  • ASYS 141.9K
  • Earning Date
  • NRXP 11-17-2025
  • ASYS 12-08-2025
  • Dividend Yield
  • NRXP N/A
  • ASYS N/A
  • EPS Growth
  • NRXP N/A
  • ASYS N/A
  • EPS
  • NRXP N/A
  • ASYS N/A
  • Revenue
  • NRXP $242,000.00
  • ASYS $83,634,000.00
  • Revenue This Year
  • NRXP N/A
  • ASYS N/A
  • Revenue Next Year
  • NRXP $395.09
  • ASYS $12.93
  • P/E Ratio
  • NRXP N/A
  • ASYS N/A
  • Revenue Growth
  • NRXP N/A
  • ASYS N/A
  • 52 Week Low
  • NRXP $1.13
  • ASYS $3.20
  • 52 Week High
  • NRXP $6.01
  • ASYS $10.80
  • Technical
  • Relative Strength Index (RSI)
  • NRXP 31.88
  • ASYS 42.41
  • Support Level
  • NRXP $2.04
  • ASYS $6.91
  • Resistance Level
  • NRXP $2.81
  • ASYS $7.41
  • Average True Range (ATR)
  • NRXP 0.22
  • ASYS 0.37
  • MACD
  • NRXP -0.06
  • ASYS -0.01
  • Stochastic Oscillator
  • NRXP 7.41
  • ASYS 30.56

About NRXP NRX Pharmaceuticals Inc.

NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.

About ASYS Amtech Systems Inc.

Amtech Systems Inc is a manufacturer of capital equipment, including thermal processing and wafer polishing, and related consumables used in fabricating semiconductor devices, such as silicon carbide (SiC) and silicon power chips, electronic assemblies, and light-emitting diodes (LEDs). the company has two segments; based on the industries served: Thermal Processing Solutions (formerly called Semiconductor) and Semiconductor Fabrication Solutions (formerly called Material and Substrate). Maximum revenue is generated from Thermal Processing Solutions. Maximum revenue is from Asia Region.

Share on Social Networks: